Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 9789619)

1.

Can somatostatin be administered in association with morphine in advanced cancer patients with pain?

Ripamonti C, De Conno F, Boffi R, Ascani L, Bianchi M.

Ann Oncol. 1998 Aug;9(8):921-3. No abstract available.

2.
3.

Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better.

Duarte Souza JF, Lajolo PP, Pinczowski H, del Giglio A.

Support Care Cancer. 2007 Nov;15(11):1319-23. Epub 2007 Sep 6.

PMID:
17805582
4.

Opioid tolerance in adult and neonatal rats.

Pan ZZ.

Methods Mol Med. 2003;84:223-32. No abstract available.

PMID:
12703327
5.

Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer.

Ishiyama H, Shibata A, Niino K, Hosoya T.

Support Care Cancer. 2004 Oct;12(10):743-5.

PMID:
15290428
6.

[Continuous subcutaneous opioid infusion in cancer pain therapy].

Schoon W, Erdmann H, Kleeberg UR.

Med Klin (Munich). 1987 Nov 13;82(23):805-11. German. No abstract available.

PMID:
2893248
7.

Low morphine doses in opioid-naive cancer patients with pain.

Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W, Villari P, Arcuri E.

J Pain Symptom Manage. 2006 Mar;31(3):242-7.

PMID:
16563318
9.

Morphine in nonmalignant joint pain. Physiological rationale, value, and limitations.

Perrot S.

Rev Rhum Engl Ed. 1999 May;66(5):271-7. Review. No abstract available.

PMID:
10380259
10.
11.

Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.

Geppetti P, Benemei S.

Clin Drug Investig. 2009;29 Suppl 1:3-16. doi: 10.2165/0044011-200929001-00002. Review.

PMID:
19445550
12.

A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.

Guest JF, Ruiz FJ, Russ J, Gupta RD, Mihai A, Greener M.

Curr Med Res Opin. 2005 Feb;21(2):271-80.

PMID:
15801998
13.

Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.

Bardin L, Colpaert FC.

Eur J Pain. 2004 Jun;8(3):253-61.

PMID:
15109976
14.

Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.

Gallantine EL, Meert TF.

Basic Clin Pharmacol Toxicol. 2008 Nov;103(5):419-27. doi: 10.1111/j.1742-7843.2008.00306.x. Epub 2008 Aug 11.

PMID:
18699797
15.
16.

Interactions of "ultra-low" doses of naltrexone and morphine in mature and young male and female rats.

Hamann SR, Malik H, Sloan JW, Wala EP.

Receptors Channels. 2004;10(2):73-81.

PMID:
15204037
17.

Pharmacological evaluation of morphine and non-opioid analgesic adjuvants in a mouse model of skin cancer pain.

Andoh T, Sugiyama K, Fujita M, Iida Y, Nojima H, Saiki I, Kuraishi Y.

Biol Pharm Bull. 2008 Mar;31(3):520-2.

18.
19.

Morphine applied to the ventrolateral orbital cortex produces a naloxone-reversible antinociception in the rat.

Huang X, Tang JS, Yuan B, Jia H.

Neurosci Lett. 2001 Feb 23;299(3):189-92.

PMID:
11165767
20.

Opioid conversion guidelines for managing adult cancer pain.

Derby SA.

Am J Nurs. 1999 Oct;99(10):62-5. No abstract available.

PMID:
10542852
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk